CISION PRNewswire

35932 posts
EarFun Debuts All-New Tune Pro Delivers Outstanding Performance with 120 Hour Playback, Hi-Res Audio, and AI Noise Cancelling

EarFun Debuts All-New Tune Pro Delivers Outstanding Performance with 120 Hour Playback, Hi-Res Audio, and AI Noise Cancelling

SANTA MONICA, Calif., May 21, 2025 /PRNewswire/ — The all-new EarFun Tune Pro…
STRADVISION Maintains ISO/IEC 27001 & 27701 Information Security Certifications for Five Consecutive Years

STRADVISION Maintains ISO/IEC 27001 & 27701 Information Security Certifications for Five Consecutive Years

In the era of autonomous driving, security is more than just technology;…

Shaping the AIoT Era: Fibocom Showcases Next-Gen Edge Intelligence at COMPUTEX 2025

TAIPEI, May 20, 2025 /PRNewswire/ — Fibocom, a global leading provider of…
BLUETTI Launches Apex 300 on Indiegogo: Versatile Power for Homes, Travel & Off-Grid Living

BLUETTI Launches Apex 300 on Indiegogo: Versatile Power for Homes, Travel & Off-Grid Living

SYDNEY, May 21, 2025 /PRNewswire/ — BLUETTI, a technology pioneer in clean energy,…
BLUETTI Launches Apex 300 on Indiegogo: Versatile Power Station for Home Backup, RVs and Off-grid Life

BLUETTI Launches Apex 300 on Indiegogo: Versatile Power Station for Home Backup, RVs and Off-grid Life

From a plug-and-play to a whole-home backup, Apex 300 redefines portable power,…
Global Prosperity Summit 2025 highlights Hong Kong's role as a super-connector as experts from around the world convene to discuss space innovation, AI and the trade war

Global Prosperity Summit 2025 highlights Hong Kong's role as a super-connector as experts from around the world convene to discuss space innovation, AI and the trade war

HONG KONG, May 20, 2025 /PRNewswire/ — Today marked the opening of…
Science and Technology Daily: Into Tech Park: Zooming In on China's Innovative Spirit

Science and Technology Daily: Into Tech Park: Zooming In on China's Innovative Spirit

TIANJIN, China, May 20, 2025 /PRNewswire/ — Imagine controlling objects with your…

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

The first heavily pretreated r/r FL patient dosed at City of Hope…